|
|
|
|
|
| (11) | Liudijimo numeris | |
| (68) | Patento numeris | 4129330 |
| (21) | Paraiškos papildomos apsaugos liudijimui gauti numeris | PA 2024 503 |
| (22) | Paraiškos papildomos apsaugos liudijimui gauti padavimo data | 2024-03-05 |
| (41) | Paraiškos papildomos apsaugos liudijimui gauti paskelbimo data | 2024-03-25 |
| Liudijimo paskelbimo data | ||
| (24) | Liudijimo įsigaliojimo data |
| (71) |
Takeda Vaccines, Inc. ,
75 Sidney Street, Cambridge, MA 02139,
US
The Government of The United States of America as represented by The Secretary of The Department of Health and Human Services , 4770 Buford Highway Technology Transfer Office (K79), Atlanta, GA 30341, US |
| (73) |
Takeda Vaccines, Inc. ,
75 Sidney Street, Cambridge, MA 02139,
US
The Government of The United States of America as represented by The Secretary of The Department of Health and Human Services , 4770 Buford Highway Technology Transfer Office (K79), Atlanta, GA 30341, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/22/1699, 2022-12-05 |
| (95) | Denge karštligės keturvalentė vakcina (gyva, susilpninta) |
| PA paraiška paskelbta |